SCHEMBL31160000

SCHEMBL31160000

CCNc1cc(C(=O)OC)cc(OC(C)C)c1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ KDM4E B2RXH2 5/20 0.40
▸ GAA P10253 2/20 0.40
▸ THRB P10828 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ PLEC Q15149 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ EP300 Q09472 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ERAP2 Q6P179 2/20 0.37
▸ LNPEP Q9UIQ6 2/20 0.37
▸ PDE4B Q07343 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1457837 0.84 CA12 (0.46) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL31160123 0.80 MAPT (0.41) MAPTALDH1A1GAAHTTHSD17B10
SCHEMBL31160045 0.75 CA12 (0.45) MAPTALDH1A1KDM4EHPGDHTT
SCHEMBL31159824 0.74 KDM4E (0.42) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL7928469 0.74 ALDH1A1 (0.52) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL5218033 0.73 HCAR3 (0.52) MAPTALDH1A1KDM4EHTTLMNA
SCHEMBL31160054 0.72 MAPT (0.43) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL27255559 0.72 KDM4E (0.45) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL31463453 0.72 KMT2A (0.37) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL31463454 0.72 KMT2A (0.37) MAPTALDH1A1KDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688144-A1 COMPOUNDS AS GLP-1R AGONISTS Terns Pharmaceuticals, Inc. (US) 2026-02-11 — — EP disclosed
WO-2024206878-A1 COMPOUNDS AS GLP-1R AGONISTS TERNS PHARMACEUTICALS, INC. (US) 2024-10-03 — — WO disclosed
Send feedback